🧬 Logic-Driven Therapeutics Platform

Launch YourBiotech Startup

Moleculogic empowers domain-fit founders with SEI-generated therapeutic blueprints, IND-ready packages, and investor-grade strategies—engineered for precision, reproducibility, and clinical impact.

30+
Active Founders
80%
Failure Reduction
11
Weeks to IND
3
Flagship Molecules
Begin OnboardingContact Ebima
🧬

Molecule Design & SEI Logic

Custom therapeutic blueprints with full logic traceability, entropy audits, and causality mapping.

📑

IND-Ready Documentation

Comprehensive packages with safety profiles, mechanism blueprints, and SEI validation for regulatory submission.

📈

Fundraising & Pitch Support

Investor-ready decks, logic-driven positioning, and milestone roadmaps for capital traction.

🤝

Moleculogic Collective

Access a curated founder network for shared insights, strategic introductions, and collaborative growth.

The Moleculogic Flywheel

StageActionOutcome
1️⃣Moleculogic designs moleculeTailored to founder’s domain expertise
2️⃣Founder raises capitalLeverages SEI audit trail and blueprint
3️⃣Moleculogic licenses more blueprintsSuccess drives demand and credibility
4️⃣Moleculogic becomes industry standardPowers 30+ ventures with logic-driven innovation

Platform leverage without platform exposure.

What You Need to Execute

Your licensing kit equips you to move from molecule to market with confidence:

📦
Moleculogic Licensing Kit – Blueprint summary, SEI logic trace, safety profile, pitch pack, and license terms (royalty/equity).
✅
Founder Intake System – Rigorous intake process ensures domain-fit founders receive tailored blueprints.
🛡️
SEI Governance Layer – Ensures blueprint fidelity, prevents drift, and maintains scientific integrity.
🔬
Molecule Preview Access – Explore GRX‑REGEN‑χ1, AIM001‑SEI‑T2, TREGBAL‑χ1, and more post-onboarding.
⚠️
License Revocation Clause – Licenses are revocable on misuse or breach of SEI governance standards.
💬
“Moleculogic’s QRX‑3 blueprint for chronic kidney disease was logic-traced and IND-ready, enabling us to file an eCTD package in just 11 weeks. This is biotech built on conviction, not chance.”
EC
Ebima Clifford Okundaye
Founder, NeuKidey Inc

Current Flagship Blueprints

Explore our current portfolio of logic-driven therapeutic molecules designed for immediate clinical impact.

GRX‑REGEN‑χ1

Reverses hair graying via McSC reactivation and MITF-regulated ROS recovery. Targets dermatology and longevity platforms.

Preclinical Ready

AIM001‑SEI‑T2

Restores anti-tumor function by auditing MDSC-TAM entropy collapse. Targets immuno-oncology sponsors.

Blueprint Complete

FDC‑TREGBAL‑χ1

Corrects T-cell collapse without IL-2 dependency. Targets autoimmune and tolerance-restoration sponsors.

Proposal Ready

Your Journey to Success

Three simple steps to launch your biotech startup

📝
STEP 01

Submit Onboarding

Complete our founder intake process

🧬
STEP 02

Molecule Design

Receive your custom SEI blueprint

🚀
STEP 03

Launch & Scale

Raise capital and build your startup

Ready to Transform Healthcare?

Join the Moleculogic ecosystem and launch with logic-driven precision.

Start Your JourneyContact Ebima

Step 1: Intake Form → Step 2: Molecule Match → Step 3: Blueprint Delivered